National Health Investors, Inc.
NHI
$78.49
-$0.12-0.15%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.86% | 10.74% | 8.34% | 1.71% | 7.89% |
| Total Other Revenue | 12.70% | 6.94% | 3.49% | 9.94% | 14.90% |
| Total Revenue | 8.19% | 9.83% | 7.17% | 3.54% | 9.41% |
| Cost of Revenue | -12.96% | 5.12% | -7.10% | 4.45% | 315.13% |
| Gross Profit | 12.24% | 10.73% | 7.15% | 3.37% | -4.11% |
| SG&A Expenses | 43.40% | 40.44% | 15.04% | 12.30% | 12.39% |
| Depreciation & Amortization | 13.88% | 9.44% | 9.17% | 1.44% | -1.35% |
| Other Operating Expenses | 417.02% | 243.85% | 6.95% | 4,050.00% | -99.53% |
| Total Operating Expenses | 8.37% | 14.22% | 9.09% | 4.19% | 2.30% |
| Operating Income | 8.06% | 6.34% | 5.67% | 3.04% | 15.36% |
| Income Before Tax | 4.97% | 10.31% | 34.89% | -2.72% | -11.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.97% | 10.31% | 34.89% | -2.72% | -11.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.97% | 20.00% | 39.14% | -4.79% | -8.43% |
| Net Income | 4.91% | 10.40% | 34.94% | -2.75% | -11.37% |
| EBIT | 8.06% | 6.34% | 5.67% | 3.04% | 15.36% |
| EBITDA | 9.59% | 7.20% | 6.64% | 2.60% | 10.43% |
| EPS Basic | -2.54% | 4.72% | 29.77% | -2.97% | -11.43% |
| Normalized Basic EPS | -0.40% | 4.81% | 3.60% | 4.02% | 20.17% |
| EPS Diluted | -2.47% | 4.23% | 29.13% | -3.83% | -11.61% |
| Normalized Diluted EPS | -0.28% | 4.52% | 2.87% | 2.80% | 19.69% |
| Average Basic Shares Outstanding | 7.59% | 5.37% | 3.98% | 0.20% | 0.02% |
| Average Diluted Shares Outstanding | 7.48% | 5.65% | 4.72% | 1.38% | 0.40% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.03% | -0.05% | -0.26% | 0.03% | 0.13% |